Related Experiment Videos
Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection
R A Wrightsman1, M J Miller, J L Saborio
1Department of Molecular Biology and Biochemistry, University of California-Irvine 92717.
Abstract:
The paraflagellar rod proteins (PAR) purified from Trypanosoma cruzi epimastigotes were shown to protect mice against an otherwise lethal challenge inoculum of 10(3) bloodstream-form trypomastigotes. The injection route used for immunization was shown to have a marked impact on the development of protective immunity. Mice receiving subcutaneous (s.c.) injections of PAR proteins had reduced bloodstream parasitemias and showed 100% survival following challenge. In contrast, mice immunized via the intraperitoneal (i.p.) route developed parasitemia levels equivalent to those of unimmunized controls and did not survive infection. Western blotting (immunoblotting) demonstrated that sera from both i.p. and s.c. immunized mice reacted specifically with PAR proteins; however, the antibody titer of the i.p. immunized mice was approximately 64-fold greater than that of the s.c. immunized mice, suggesting that the protective response in the s.c. immunized mice is cell mediated rather than humoral.
Insights
Paraflagellar rod (PAR) proteins from Trypanosoma cruzi protect mice against lethal infection. Subcutaneous immunization with PAR proteins induced protective immunity, while intraperitoneal injection did not, indicating a cell-mediated immune response is crucial for protection.
Area of Science:
- Immunology
- Parasitology
- Molecular Biology
Background:
- Trypanosoma cruzi causes Chagas disease, a significant human health concern.
- Developing effective vaccines against T. cruzi remains a challenge.
- Paraflagellar rod (PAR) proteins are potential vaccine candidates.
Purpose of the Study:
- To evaluate the protective efficacy of Trypanosoma cruzi paraflagellar rod (PAR) proteins in a mouse model.
- To investigate the impact of immunization route on the development of protective immunity against T. cruzi infection.
Main Methods:
- Purification of PAR proteins from T. cruzi epimastigotes.
- Immunization of mice using subcutaneous (s.c.) and intraperitoneal (i.p.) routes.
- Challenge with a lethal inoculum of bloodstream-form T. cruzi.
- Monitoring parasitemia and survival rates.
- Western blotting (immunoblotting) to analyze antibody responses.
Main Results:
- Subcutaneous immunization with PAR proteins resulted in 100% survival and reduced parasitemia in mice.
- Intraperitoneal immunization did not confer protection, with parasitemia levels similar to controls.
- While both routes generated antibodies against PAR proteins, the s.c. route elicited a protective, likely cell-mediated, immune response.
Conclusions:
- The route of immunization significantly influences the efficacy of PAR protein-based protection against T. cruzi.
- Subcutaneous administration of PAR proteins induces a cell-mediated immune response crucial for protection.
- PAR proteins are promising candidates for a T. cruzi vaccine, with route optimization being key.